Norges Bank’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,208,813
Closed -$5.97M 2131
2022
Q4
$5.97M Hold
1,208,813
﹤0.01% 1728
2022
Q3
$8M Hold
1,208,813
﹤0.01% 1609
2022
Q2
$6.72M Sell
1,208,813
-12,903
-1% -$98.8K ﹤0.01% 1687
2022
Q1
$12.4M Sell
1,221,716
-100,000
-8% -$878K ﹤0.01% 1619
2021
Q4
$12.6M Sell
1,321,716
-149,365
-10% -$1.58M ﹤0.01% 1674
2021
Q3
$21.3M Sell
1,471,081
-464,926
-24% -$8.95M ﹤0.01% 1444
2021
Q2
$53.9M Buy
+1,936,007
New +$51.1M 0.01% 916

Other funds holding LFST

Norges Bank's LFST Position: Q1 2023 in Review

Norges Bank sold out of Lifestance Health (LFST) in Q1 2023, closing a stake of 1,208,813 shares — an estimated $5.97M sold.

Norges Bank first reported a position in LFST in Q2 2021 and held it in 7 quarters. The position peaked at $53.9M in Q2 2021. 89 funds tracked by Wall St. Rank hold LFST as of Q1 2023.

  • Norges Bank reported no remaining Lifestance Health position as of Q1 2023 after selling out during the quarter.
  • Norges Bank sold 1,208,813 Lifestance Health shares in Q1 2023, an estimated $5.97M.
  • Norges Bank first reported a position in Lifestance Health in Q2 2021 and held it in 7 quarters.
  • Norges Bank's Lifestance Health position peaked at $53.9M in Q2 2021.
  • 89 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2023.

Based on Norges Bank's 13F filing for Q1 2023, filed 15 May 2023.